scholarly journals The Status of the EGFR T790M Mutation is associated with the Clinical Benefits of Osimertinib Treatment in Non-small Cell Lung Cancer Patients: A Meta-Analysis

2020 ◽  
Vol 11 (11) ◽  
pp. 3106-3113
Author(s):  
Zhe Zhao ◽  
Lu Li ◽  
Zhijie Wang ◽  
Jianchun Duan ◽  
Hua Bai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Meta Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
T790m Mutation ◽  
Lung Cancer Patients ◽  
The Status ◽  
Clinical Benefits ◽  
Egfr T790m

scholarly journals Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

2011 ◽  
Vol 17 (5) ◽  
pp. 1160-1168 ◽  
Author(s):  
Rafael Rosell ◽  
Miguel Angel Molina ◽  
Carlota Costa ◽  
Sara Simonetti ◽  
Ana Gimenez-Capitan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Egfr Mutations ◽  
Small Cell Lung ◽  
T790m Mutation ◽  
Lung Cancer Patients ◽  
Brca1 Mrna ◽  
Egfr T790m
Sign in / Sign up

Export Citation Format

Share Document